Episode Details

Executive Summary & Company Overview Eli Lilly and Company (LLY) has undergone a profound strategic transformation, evolving from a diversified pharmaceutical firm into a highly focused innovator, primarily centered on cardiometabolic health, oncology, immunology, and neuroscience. The company operates as a single business segment dedicated to the discovery, development, manufacturing, and sale of human pharmaceutical […]